Silverback Therapeutics CEO Laura Shawver receives $14M in 2020
Silverback Therapeutics reports 2020 executive compensation
By ExecPay News
Published: 1 minutes ago
Silverback Therapeutics reported fiscal year 2020 executive compensation information on April 22, 2021.
In 2020, four executives at Silverback Therapeutics received on average a compensation package of $6.9M, a 1,570% increase compared to previous year.
Average pay of disclosed executives at Silverback Therapeutics
Laura Shawver, Chief Executive Officer, received $14M in total. 95% of Shawver's compensation, or $13M, was in option awards. Shawver also received $284K in non-equity incentive plan, $325K in salary, as well as $44K in other compensation.
Valerie Odegard, Chief Scientific Officer, received a compensation package of $7.2M, which increased by 1624% compared to previous year. 92% of the compensation package, or $6.6M, was in option awards.
Jonathan Piazza, Chief Financial Officer, earned $6.2M in 2020.
Peter Thompson, Chief Executive Officer, received $552K in 2020.
Related executives
You may also like
Source: SEC filing on April 22, 2021.